Search all trials

Find therapies in clinical trials near you – page 12

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Non-small cell lung cancer recurrent+1

Not recruiting

Registered drugNo placebo

Study of subcutaneous nivolumab with ipilimumab and chemotherapy in previously untreated patients with metastatic or recurrent non-small cell lung cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Non-small cell lung cancer stage IV+1

Not recruiting

InvestigationalNo placebo

Study of Zelenectide Pevedotin in Adults with Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer with NECTIN4 Amplification

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:ZELENECTIDE PEVEDOTIN

Contact Research Centre

Small cell lung cancer

Not recruiting

Registered drugNo placebo

Study of Tarlatamab Treatment in Patients with Small Cell Lung Cancer: Evaluation of Different Dosing Schedules

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Siltuximab

Contact Research Centre

Bladder transitional cell carcinoma

Not recruiting

Registered drug

Study on the Effectiveness of Durvalumab and BCG in Treating High-Risk, Non-Muscle Invasive Bladder Cancer in Patients New to BCG Treatment

Registered drug

France

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Durvalumab

Contact Research Centre

Non-small cell lung cancer metastatic

Not recruiting

InvestigationalNo placebo

Study of M9140 for Patients with Advanced Non-Small Cell Lung Cancer

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years

Contact Research Centre

Metastatic gastric cancer

Not recruiting

InvestigationalNo placebo

Study of M9140 for Patients with Advanced Stomach Cancer

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years

Contact Research Centre

Asthma

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Benralizumab with Budesonide and Formoterol in Patients with Eosinophilic Asthma Uncontrolled by Standard Treatment

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Benralizumab

Contact Research Centre

Transitional cell carcinoma+1

Not recruiting

Registered drugNo placebo

Study of Livmoniplimab and Budigalimab Compared to Chemotherapy for Adults with Advanced Bladder Cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Budigalimab

Contact Research Centre

Non-small cell lung cancer stage IV

Not recruiting

Registered drugNo placebo

Study on Continuing Nivolumab and Ipilimumab Treatment vs. Observation in Patients with Stage IV Non-Small Cell Lung Cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Ipilimumab

Contact Research Centre

Asthma

Not recruiting

Registered drugNo placebo

Study on Omalizumab and Mepolizumab for Patients with Severe Allergic and Eosinophilic Asthma

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Mepolizumab

Contact Research Centre

Immune thrombocytopenia

Not recruiting

Registered drug

Study of rituximab and belimumab combination compared to rituximab alone in adults with persistent or chronic immune thrombocytopenia (ITP)

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Belimumab

Contact Research Centre

Non-small cell lung cancer stage IV

Not recruiting

Registered drugNo placebo

Study of Atezolizumab, Carboplatin, and Paclitaxel for Elderly Patients with Advanced Non-Small Cell Lung Cancer

Registered drugNo placebo

France

Participants:65+ years
Substances:Atezolizumab

Contact Research Centre

Find therapies in clinical trials near you – page 12

223 trials match your criteria

Non-small cell lung cancer recurrent+1

Study of subcutaneous nivolumab with ipilimumab and chemotherapy in previously untreated patients with metastatic or recurrent non-small cell lung cancer

Non-small cell lung cancer stage IV+1

Study of Zelenectide Pevedotin in Adults with Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer with NECTIN4 Amplification

Small cell lung cancer

Study of Tarlatamab Treatment in Patients with Small Cell Lung Cancer: Evaluation of Different Dosing Schedules

Bladder transitional cell carcinoma

Study on the Effectiveness of Durvalumab and BCG in Treating High-Risk, Non-Muscle Invasive Bladder Cancer in Patients New to BCG Treatment

Non-small cell lung cancer metastatic

Study of M9140 for Patients with Advanced Non-Small Cell Lung Cancer

Metastatic gastric cancer

Study of M9140 for Patients with Advanced Stomach Cancer

Asthma

Study on the Effectiveness and Safety of Benralizumab with Budesonide and Formoterol in Patients with Eosinophilic Asthma Uncontrolled by Standard Treatment

Transitional cell carcinoma+1

Study of Livmoniplimab and Budigalimab Compared to Chemotherapy for Adults with Advanced Bladder Cancer

Non-small cell lung cancer stage IV

Study on Continuing Nivolumab and Ipilimumab Treatment vs. Observation in Patients with Stage IV Non-Small Cell Lung Cancer

Asthma

Study on Omalizumab and Mepolizumab for Patients with Severe Allergic and Eosinophilic Asthma

Immune thrombocytopenia

Study of rituximab and belimumab combination compared to rituximab alone in adults with persistent or chronic immune thrombocytopenia (ITP)

Non-small cell lung cancer stage IV

Study of Atezolizumab, Carboplatin, and Paclitaxel for Elderly Patients with Advanced Non-Small Cell Lung Cancer

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.